Drug Price Trends for TRI-VYLIBRA LO TABLET

Average Pharmacy Cost for TRI-VYLIBRA LO TABLET

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
TRI-VYLIBRA LO TABLET	50102-0231-01	0.10073	EACH	2024-12-18
TRI-VYLIBRA LO TABLET	50102-0231-11	0.10073	EACH	2024-12-18
TRI-VYLIBRA LO TABLET	50102-0231-13	0.10073	EACH	2024-12-18
TRI-VYLIBRA LO TABLET	50102-0231-01	0.09034	EACH	2024-11-20
TRI-VYLIBRA LO TABLET	50102-0231-13	0.09034	EACH	2024-11-20
TRI-VYLIBRA LO TABLET	50102-0231-11	0.09034	EACH	2024-11-20
TRI-VYLIBRA LO TABLET	50102-0231-13	0.11947	EACH	2024-10-23

Market Analysis and Price Projections for Tri-VyLibra Lo Tablets

Introduction to Tri-VyLibra Lo

Tri-VyLibra Lo is an AB-rated generic oral contraceptive, containing the active ingredients norgestimate and ethinyl estradiol. It is designed to prevent pregnancy and is available in a triphasic administration regimen, which means the dosage of the hormones changes throughout the 28-day cycle[1][3].

Market Demand and Competition

Market Demand

The demand for oral contraceptives remains steady due to their effectiveness and widespread use. Tri-VyLibra Lo, being a generic version of popular brands like Ortho Tri-Cyclen Lo, Tri-Lo-Estarylla, and others, benefits from the established market for these medications. The need for affordable and reliable contraceptive options drives the demand for generic alternatives like Tri-VyLibra Lo.

Competition

The market for oral contraceptives is highly competitive, with numerous brand-name and generic options available. Tri-VyLibra Lo competes directly with other generic and brand-name triphasic oral contraceptives. However, its AB-rated status, which indicates bioequivalence to the brand-name versions, helps it maintain a strong market position[1][3].

Pricing and Cost Analysis

Current Pricing

The pricing of Tri-VyLibra Lo varies depending on the distributor and the location. On average, a 28-tablet pack of Tri-VyLibra Lo can cost around $40 to $80 without insurance, making it a more affordable option compared to some brand-name counterparts[2].

Cost Comparison

• Generic vs. Brand Name: Tri-VyLibra Lo, as a generic, is generally cheaper than brand-name oral contraceptives. For example, Ortho Tri-Cyclen Lo, a brand-name equivalent, can cost significantly more, often in the range of $70 to $100 for a 28-tablet pack[2].
• Insurance Coverage: Many insurance plans cover Tri-VyLibra Lo, which can reduce the out-of-pocket cost for consumers. Under some Medicare Part D plans, the cost can be as low as $10 to $25 per month, depending on the tier and coverage[5].

Price Projections

Short-Term Projections

In the short term, the price of Tri-VyLibra Lo is likely to remain stable due to its established market presence and the competitive nature of the generic pharmaceutical market. Any significant price changes would likely be driven by changes in raw material costs, manufacturing expenses, or shifts in market demand.

Long-Term Projections

• Market Saturation: As more generic versions of oral contraceptives enter the market, there could be downward pressure on prices. However, Tri-VyLibra Lo's reputation and bioequivalence to brand-name products should help it maintain its market share.
• Regulatory Changes: Changes in healthcare policies or regulations could impact the pricing and availability of Tri-VyLibra Lo. For instance, expanded insurance coverage or government initiatives to reduce healthcare costs could lead to lower prices for consumers.
• Technological Advancements: Advances in pharmaceutical technology might lead to more efficient manufacturing processes, potentially reducing the cost of production and, subsequently, the retail price.

Distribution and Accessibility

Distribution Channels

Tri-VyLibra Lo is distributed through various channels, including major pharmaceutical distributors such as ANDA, ASD Healthcare, Cardinal Health, McKesson, and Morris & Dickson. This widespread distribution ensures that the product is readily available to healthcare providers and pharmacies across the country[1].

Accessibility

The drug is available in a 28-tablet blister pack, which includes 21 active tablets and 7 placebo tablets. This packaging helps in ease of administration and adherence to the treatment regimen. The availability of Tri-VyLibra Lo through multiple distributors and its inclusion in many insurance plans enhance its accessibility to a broad range of consumers[1][3].

Consumer Feedback and Satisfaction

User Reviews

Consumer feedback on Tri-VyLibra Lo has been positive, with a 10 out of 10 average rating from reviewers on platforms like Drugs.com. Users have reported high satisfaction rates, with 100% of reviewers reporting a positive effect and no negative effects reported[4].

Side Effects and Tolerability

While Tri-VyLibra Lo is generally well-tolerated, common side effects include headache/migraine, nausea/vomiting, breast issues, and menstrual disorders. Despite these potential side effects, the overall satisfaction rate among users remains high, indicating that the benefits of the medication often outweigh the drawbacks[1][3].

Regulatory Considerations

Warnings and Precautions

Tri-VyLibra Lo comes with several warnings and precautions, including the risk of serious cardiovascular events, especially in women over 35 who smoke. It is also contraindicated in women with uncontrolled hypertension or certain liver conditions. These regulatory considerations are crucial for both prescribers and consumers to ensure safe use[3].

Contraindications

The medication is contraindicated in women with certain medical conditions, such as uncontrolled hypertension, vascular disease, and a history of thrombotic or hemorrhagic strokes. These contraindications are important for healthcare providers to consider when prescribing Tri-VyLibra Lo[3].

Key Takeaways

• Market Demand: Steady demand driven by the need for effective and affordable contraceptive options.
• Pricing: Generally more affordable than brand-name counterparts, with prices ranging from $40 to $80 per pack.
• Distribution: Widely available through multiple distributors and included in many insurance plans.
• Consumer Satisfaction: High satisfaction rates among users, despite potential side effects.
• Regulatory Considerations: Important warnings and contraindications that must be considered for safe use.

FAQs

Q: What is Tri-VyLibra Lo used for?

A: Tri-VyLibra Lo is used to prevent pregnancy in women. It is also sometimes prescribed to treat moderate acne vulgaris.

Q: How does Tri-VyLibra Lo work?

A: Tri-VyLibra Lo works by combining the hormones norgestimate and ethinyl estradiol to prevent ovulation and thicken cervical mucus, making it harder for sperm to reach the egg.

Q: What are the common side effects of Tri-VyLibra Lo?

A: Common side effects include headache/migraine, nausea/vomiting, breast issues, abdominal pain, and menstrual disorders.

Q: Is Tri-VyLibra Lo covered by insurance?

A: Yes, Tri-VyLibra Lo is often covered by insurance plans, which can significantly reduce the out-of-pocket cost for consumers.

Q: Can Tri-VyLibra Lo be used by women with certain medical conditions?

A: No, Tri-VyLibra Lo is contraindicated in women with certain medical conditions such as uncontrolled hypertension, vascular disease, and a history of thrombotic or hemorrhagic strokes.

Sources

1. Afaxys Pharma: Tri-VyLibra® Lo (norgestimate and ethinyl estradiol tablets, USP)
2. DrugBank: Norgestimate: Uses, Interactions, Mechanism of Action
3. Drugs.com: Tri-Vylibra Lo: Package Insert / Prescribing Information
4. Drugs.com: Tri-Vylibra Lo Comparison
5. Maryland Department of Budget and Management: CY20 Medicare Part D Formulary List